“Prognostic Use Of Fasting Lipid Profile, Erythrocyte Sedimentation Rate And C - Reactive Protein In The Management Of Hypertensive Individuals With Chronic Kidney Disease”, Journal of Pharmaceutical Negative Results, vol. 13, pp. 1702–1706, Nov. 2022, doi: 10.47750/pnr.2022.13. S05.267.